ACE2 | Angiotensin-Converting Enzyme 2 |
ALL | Acute Lymphocytic Leukemia |
AML | acute myeloid leukemia |
Ang-2 | Angiopoietin-2 |
BCVA | Best-Corrected Visual Acuity |
BiTE | Bispecific T cell Engager |
bNAbs | broadly Neutralizing Antibodies |
CEA | Carcinoembryonic antigen |
CMC | Chemistry, Manufacturing, and Controls |
CNS | Central Nervous System |
DAF | Dual Acting Fab |
DME | Diabetic Macular Edema |
DSP | Downstream Processing |
DVD-Ig | Dual Variable Domain-Ig |
FDA | Federal Drug Administration |
FAP | Fibroblast Activation Protein |
FIT-Ig | Fabs-In-Tandem-Ig |
Ig | Immunoglobulin |
KiH | Knobs-into-Holes |
NKCE | NK Cell Engager |
SAR | Synthetic Agonistic Receptor |
TCB | T-Cell Bispecific Antibody |
TCR | T-Cell Receptor |
TfR | Transferrin Receptor |
TNFR | TNF Receptor |
USP | Upstream Processing |
VEGF-A | Vascular Endothelial Growth Factor-A |
wAMD | wet Age-Related Macular Degeneration |